Validation of two global impression questionnaires for incontinence

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 1, 2003, Pages 98-101

  Yalcin, Ilker ^a   Bump, Richard C ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Duloxetine; Global Assessment Questionnaire; Quality of life; Stress urinary incontinence

Indexed keywords

DULOXETINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PATIENT GLOBAL IMPRESSION OF SEVERITY AND OF IMPROVEMENT; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; URINE INCONTINENCE; VALIDATION PROCESS;

EID: 0038336572     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.379     Document Type: Article

References (13)

1. Donovan J, Naughton M, Gotoh M, Corcos J, Jackson S, Kelleher C, et al. Symptom and quality of life assessment. In: Abrams P, Shoury S, Wein A, editors. Incontinence. Plymouth, UK: Health Publication; 1999. p. 295-332.
2. Mattiasson A, Peters T, Schaefer W, Blaivas J, Jonas U, Stanton S, et al. Research methodology in incontinence. In: Abrams P, Shoury S, Wein A, editors. Incontinence. Plymouth, UK: Health Publication; 1999. p. 893-929.
3. Mattiasson A, Djurhuus JC, Fonda D, Lose G, Nordling J, Stohrer M. Standarization of outcome studies in patients with lower urinary tract dysfunction: a report on general principles from the Standardisation Committee of the International Continence Society. Neururol Urodyn 1998;17:249-53.
4. Lose G, Fantl JA, Victor A, Walter S, Wells TL, Wyman J, et al. Outcome measures for research in adult women with symptoms of lower urinary tract dysfunction. Neurourol Urodyn 1998;17:255-62.
5. Wall LL, Norton P, Versi E, Bump R. Evaluating the outcome of surgery for pelvic organ prolapse. Am J Obstet Gynecol 1998;178:877-9.
6. Donovan JL, Badia X, Corcos J, Gotoh M, Kelleher C, Naughton M, et al. Symptom and quality of life assessment. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence. 2nd ed. Plymouth, UK: Health Publication; 2002. p. 267-316.
7. Feinstein AR. Global indexes and scales. In: Clinimetrics. New Haven (CT): Yale University Press; 1987. p. 91-103.
8. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA 1994;272:619-26.
9. Norton PA, Zinner NR, Yalcin I, Bump RC. Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 2002;187:40-8.
10. Zinner NR, Dmochowski RR, Norton PA, Miklos JR, Yalcin I, Bump RC. Duloxetine versus placebo in the treatment of stress urinary incontinence (SUI). Neurourol Urodyn 2002;21:383-4.
11. Wagner TH, Patrick DL, Bavendam TG, Martin ML, Buesching DP. Quality of life of persons with urinary incontinence: development of a new measure. Urology 1996;47:67-71.
12. Patrick DL, Martin ML, Bushnell DM, Yalcin I, Wagner TH, Buesching DP. Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL). Urology 1999;53:71-6.
13. Guy W. ECDEU assessment manual for psychopharmacology. Rockville (MD): National Institute of Mental Health, US Department of Health, Education, and Welfare; 1976. p. 218-22.